| P50 | author | Jeffrey R Curtis | Q87706464 |
| | Kevin L Winthrop | Q90243645 |
| P2093 | author name string | Lisa M Perry | |
| P2860 | cites work | 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis | Q26828418 |
| | A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults | Q28254168 |
| | Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study | Q30400508 |
| | TNF blockers show distinct patterns of immune response to the pandemic influenza A H1N1 vaccine in inflammatory arthritis patients. | Q30420493 |
| | Abatacept and reduced immune response to pandemic 2009 influenza A/H1N1 vaccination in patients with rheumatoid arthritis | Q30420964 |
| | Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase | Q30425783 |
| | The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination | Q33845366 |
| | Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). | Q34012075 |
| | Vaccination response to protein and carbohydrate antigens in patients with rheumatoid arthritis after rituximab treatment. | Q34027585 |
| | The delivery of evidence-based preventive care for older Americans with arthritis | Q34153010 |
| | The mortality of rheumatoid arthritis | Q34338843 |
| | Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA). | Q35350912 |
| | Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers | Q35636798 |
| | The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study | Q35840824 |
| | Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cells | Q35883435 |
| | Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor | Q35907835 |
| | Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy | Q35975369 |
| | Development and validation of a risk score for serious infection in patients with rheumatoid arthritis | Q36179586 |
| | Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases | Q36191250 |
| | Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis | Q36679769 |
| | Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases | Q36932760 |
| | Safety of zoster vaccine in elderly adults following documented herpes zoster | Q37037021 |
| | Vaccination in patients with chronic rheumatic or autoimmune diseases | Q37141193 |
| | Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study | Q39675557 |
| | Predictors of infection in rheumatoid arthritis | Q40629895 |
| | Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices--United States, 2013-2014. | Q42268487 |
| | Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab | Q44477199 |
| | Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial | Q44528888 |
| | Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older | Q45329117 |
| | Improved influenza and pneumococcal vaccination in rheumatology patients taking immunosuppressants using an electronic health record best practice alert | Q45412533 |
| | The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis | Q46107650 |
| | Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response | Q46559627 |
| | Increasing pneumococcal vaccination for immunosuppressed patients: a cluster quality improvement trial | Q46683857 |
| | Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. | Q46803679 |
| | Knowledge, attitudes, and clinical practice of rheumatologists in vaccination of the at-risk rheumatology patient population. | Q47341567 |
| | The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. | Q51024198 |
| | Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab | Q79784933 |
| | Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone | Q80182554 |
| | The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab | Q83143549 |
| | Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors | Q84745278 |
| | Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNFalpha blockers: safety and immunogenicity | Q84760318 |
| | Heptavalent pneumococcal conjugate vaccine elicits similar antibody response as standard 23-valent polysaccharide vaccine in adult patients with RA treated with immunomodulating drugs | Q85009015 |
| | Rheumatoid arthritis and herpes zoster: risk and prevention in those treated with anti-tumour necrosis factor therapy | Q85062684 |
| | Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP) | Q95432989 |
| P433 | issue | 8 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 431 | |
| P577 | publication date | 2014-08-01 | |
| P1433 | published in | Current Rheumatology Reports | Q23930052 |
| P1476 | title | Vaccinations for rheumatoid arthritis. | |
| P478 | volume | 16 | |